In vivo imaging, which enables us to peer deeply within living subjects, is producing
tremendous opportunities both for clinical diagnostics and as a research tool. Contrast …

Despite major improvements concerning its diagnosis and treatment, pancreatic ductal
adenocarcinoma (PDAC) remains an aggressive disease with an extremely poor prognosis …

The overexpression of integrin αvβ3 has been linked to tumor aggressiveness and
metastasis in several cancer types. Because of its high affinity, peptides containing the …

Pancreatic cancer is highly lethal. New diagnostic and treatment modalities are desperately
needed. We report here that an expanded porphyrin, cyclo [8] pyrrole (CP), with a high …

One of the factors limiting the translation of knowledge from preclinical studies to the clinic
has been the limitations of in vivo diseases models. Except in the case of highly controlled …

Clinical extensive application of indocyanine green (ICG) is limited by several drawbacks
such as poor bioenvironmental stability, aggregate propensity, and rapid elimination from …

Background Biomarker-targeted molecular imaging holds promise for early detection of
pancreatic cancer. The aim of this study was to design and evaluate a plectin-1 targeted …

The worldwide utilization of 68Ga‐radionuclide for the fundamental research and clinical
applications is growing exponentially. A broad range of 68Ga‐based imaging agents has …

During the last decade, the utilization of 68Ga for the development of imaging agents has
increased considerably with the leading position in the oncology. The imaging of infection …

Pancreatic ductal adenocarcinoma is highly lethal and surgical resection is the only
potential curative treatment for the disease. In this study, hyaluronic acid derived …